Previous close | 1.9900 |
Open | 1.9900 |
Bid | 2.0000 x 400 |
Ask | 2.0300 x 200 |
Day's range | 1.9700 - 2.0500 |
52-week range | 1.1100 - 3.2900 |
Volume | |
Avg. volume | 203,317 |
Market cap | 163.523M |
Beta (5Y monthly) | 0.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ProQR Therapeutics ( NASDAQ:PRQR ) Full Year 2023 Results Key Financial Results Revenue: €9.53m (up 98% from FY 2022...
Key Insights Significant control over ProQR Therapeutics by individual investors implies that the general public has...
ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.